Alpha Tau Medical (DRTSW) Operating Income (2021 - 2026)
Alpha Tau Medical (DRTSW) posted Operating Income of $13.3 million for Q1 2026, up 5.64% sequentially from $12.6 million in Q4 2025, and up 43.03% YoY from $9.3 million in Q1 2025.
Alpha Tau Medical (DRTSW) Operating Income (2021 - 2026) Analysis & Trends
Alpha Tau Medical has reported Operating Income for 6 years, with the latest figure at $13.3 million in Q1 2026.
- Quarterly Operating Income rose 43.03% year-over-year to $13.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $46.3 million (up 25.37% YoY) and the FY2025 annual result came in at $42.3 million, up 17.33% from the prior year.
- Operating Income climbed to $13.3 million in Q1 2026 per DRTSW's latest filing, from $12.6 million in the prior quarter.
- Over five years, Operating Income peaked at $13.3 million in Q1 2026 and troughed at $7.4 million in Q3 2022.
- A 5-year average of $9.4 million and a median of $8.9 million in 2023 frame the typical range for Operating Income.
- The sharpest annual moves came in 2022 and 2024: Operating Income jumped 221.06% in 2022, then decreased 7.11% in 2024.
- Over 5 years, Operating Income stood at $8.0 million in 2022, then grew by 24.52% to $9.9 million in 2023, then advanced by 3.33% to $10.3 million in 2024, then increased by 22.66% to $12.6 million in 2025, then climbed by 5.64% to $13.3 million in 2026.
- According to Business Quant data, Operating Income over the past three periods registered $13.3 million, $12.6 million, and $10.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.40 Bn | 131.54 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 86.13 Bn | 78.13 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 65.58 Bn | 60.40 Bn | 1.37 Bn | 493.00 Mn |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn | -815.00 Mn |
| 5 | BeOne Medicines | 42.18 Bn | 37.08 Bn | 1.53 Bn | 325.05 Mn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn | 231.44 Mn |
| 7 | BioNTech SE | 27.97 Bn | 9.58 Bn | 668.28 Mn | -375.75 Mn |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | -1.55 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | 133.12 Mn |
| 10 | Alpha Tau Medical | 367.64 Mn | 185.23 Mn | - | -40.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -40.41 Mn |
| Mar 31, 2026 | 13.31 Mn |
| Dec 31, 2025 | 12.60 Mn |
| Sep 30, 2025 | 10.73 Mn |
| Jun 30, 2025 | 9.65 Mn |
| Mar 31, 2025 | 9.31 Mn |
| Dec 31, 2024 | 10.27 Mn |
| Sep 30, 2024 | 8.29 Mn |
| Jun 30, 2024 | 9.05 Mn |
| Mar 31, 2024 | 8.42 Mn |
| Dec 31, 2023 | 9.94 Mn |
| Sep 30, 2023 | 8.93 Mn |
| Jun 30, 2023 | 8.17 Mn |
| Mar 31, 2023 | 8.64 Mn |
| Dec 31, 2022 | 7.99 Mn |
| Sep 30, 2022 | 7.36 Mn |
| Jun 30, 2022 | 8.01 Mn |
| Mar 31, 2022 | 8.78 Mn |
| Dec 31, 2021 | 3.94 Mn |
| Sep 30, 2021 | 3.63 Mn |